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Dedifferentiation of Mammalian Myotubes
Induced by msx1
the terminal differentiation pathway and begin to ex-
press, in succession, a number of muscle differentiation
factors. These include myogenin, the cdk inhibitor p21/
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Medicine WAF1, activated retinoblastoma protein, and the muscle
contractile proteins (e.g., myosin heavy chain and tropo-†Howard Hughes Medical Institute
‡Department of Human Genetics nin T). The differentiating cells align along their axes and
fuse to form terminally differentiated myotubes capable§Department of Pediatrics
University of Utah of muscle contraction.
This differentiation process is thought to be irrevers-Salt Lake City, Utah 84112
ible in mammalian myotubes. By contrast, urodele am-
phibians show a remarkable plasticity in cellular differ-
entiation. Urodeles are capable of regenerating severalSummary
anatomical structures, including limbs, tail, eye lenses,
retinas, upper and lower jaws, dorsal crest, spinal cord,The process of cellular differentiation culminating in
and heart ventricle (Becker et al., 1974; Davis et al.,terminally differentiated mammalian cells is thought
1990; Brockes, 1997). During limb regeneration, cellsto be irreversible. Here, we present evidence that ter-
underlying the wound epithelium dedifferentiate to formminally differentiated murine myotubes can be in-
a pool of proliferating, progenitor cells known as theduced to dedifferentiate. Ectopic expression of msx1
blastema. These cells later redifferentiate and, in con-in C2C12 myotubes reduced the nuclear muscle pro-
junction with endogenous patterning signals, a new limbteins MyoD, myogenin, MRF4, and p21 to undetect-
develops. Muscle cells are known to participate in theable levels in 20%–50% of the myotubes. Approxi-
dedifferentiation process and can contribute to the for-mately 9% of the myotubes cleave to produce either
mation of cartilage in the regenerated limb (Chalkley,smaller multinucleated myotubes or proliferating, mono-
1954; Bodemer and Everett, 1959; Hay and Fischman,nucleated cells. Finally, clonal populations of the myo-
1961; Steen, 1968; Lo et al., 1993; Kumar et al., 2000).tube-derived mononucleated cells can be induced to
A nuclear protein that may play a role in urodele cellu-redifferentiate into cells expressing chondrogenic, ad-
lar dedifferentiation is the homeobox-containing tran-ipogenic, myogenic, and osteogenic markers. These re-
scriptional repressor msx1. msx1 is expressed in thesults suggest that terminally differentiated mammalian
early regeneration blastema (Simon et al., 1995) and itsmyotubes can dedifferentiate when stimulated with
expression in the developing mouse limb demarcatesthe appropriate signals and that msx1 can contribute
the boundary between the undifferentiated (msx1-to the dedifferentiation process.
expressing) and differentiating (no msx1 expression)
cells (Hill et al., 1989; Robert et al., 1989; Simon et al.,
Introduction 1995). Furthermore, ectopic expression of either murine
or human msx1 will inhibit in vitro myogenesis in cultured
Terminally differentiated mammalian cells are thought mouse cells (Song et al., 1992; Woloshin et al., 1995).
to be incapable of undergoing a reversal of cell differen- Here, we report that the combined effects of growth
tiation. These cells have permanently exited the cell medium and ectopic msx1 expression can cause a re-
cycle in response to the expression of cyclin-dependent duction in the levels of muscle differentiation proteins
kinase (cdk) inhibitors, activation of members of the in mouse C2C12 myotubes. A subset of these myotubes
retinoblastoma family, and downregulation of cyclins cleave to produce a pool of proliferating, mononucle-
and cyclin-dependent kinases. In addition, proteins criti- ated cells that are capable of redifferentiating into differ-
cal for cellular specialization have accumulated and ent cell types that express characteristic markers of
driven these cells to their final morphology and function. chondrogenesis, adipogenesis, myogenesis, and os-
The in vitro differentiation of myocytes is a well char- teogenesis. These results suggest that terminally differ-
acterized example of terminal differentiation (Andres entiated mammalian cells, like their urodele counter-
and Walsh, 1996; Walsh and Perlman, 1997). Myoblasts parts, are capable of dedifferentiating to cells that are
are mononucleated skeletal myocytes that will prolifer- like stem cells when challenged with the appropriate
ate when cultured in the presence of growth factors. signals.
These cells are committed to the myogenic lineage
through expression of the muscle regulatory factors
ResultsMyoD and/or myf-5. When grown to cellular confluence
and deprived of growth factors, these myocytes enter
Generation of C2C12 Clones Containing
an Inducible msx1 Gene
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Figure 1. msx1 Prevents Differentiation of
Myoblasts to Myotubes
(A) LINX plasmids carrying the recombinant
retroviral construct with msx1 in the forward
or reverse orientation. 59- and 39-long termi-
nal repeats are indicated (59-LTR and 39-LTR),
as well as the c packaging signal (c), tetracy-
cline-controlled transactivator gene (tTA), in-
ternal ribosomal entry site (IRES), the neomy-
cin resistance gene (neor ), the human CMV
minimal promoter regulated by tetracycline
response elements (TRE-CMVmin-pro), and the
msx1 gene (msx1) in either the forward (fwd)
or reverse (rev) orientation.
(B) LINX-msx1-fwd and LINX-msx1-rev were
transduced into C2C12 myoblasts and clones
(Fwd-2, Fwd-3, and Rev-2) were either in-
duced or suppressed for msx1 expression.
Northern blots of total RNA were probed with
a 40 nucleotide oligomer complimentary to
the msx1 transcript. msx1 was induced (I),
suppressed (S), or induced and then sup-
pressed (I!S). LINX-msx1 is the 6.5 kb tran-
script generated from the 59-LTR retroviral
promoter and extending to the polyadenyla-
tion site in the 39-LTR. 28S denotes the 28S
ribosomal RNA band that cross-hybridizes to
the msx1 probe. msx1 is the 2.1 kb msx1
transcript.
(C) Inhibition of muscle differentiation in the
presence of msx1. Fwd-3 Suppressed and
Rev-2 Suppressed are clones in which TRE-
CMVmin-pro is suppressed by doxycycline (msx1
expression suppressed in Fwd-3 clone). Fwd-3
Induced and Rev-2 Induced are clones in
which TRE-CMVmin-pro is activated in the ab-
sence of doxycycline (msx1 expression in-
duced in Fwd-3). Myotubes form in the ab-
sence of msx1 but fail to form when msx1 is
present. Although the Fwd clones grown in
suppression conditions readily differentiated,
the myotubes that formed were smaller than
the controls, populated the plate at a lower
density, and were generally delayed in their
development by about a day. These myo-
tubes were multinucleated and appeared to
be terminally differentiated using morpho-
logic criteria and indirect immunofluores-
cence for troponin-T (data not shown). All
Fwd clones grown in suppression conditions
exhibited this altered differentiation profile,
while all Rev clones differentiated normally.
The reason for these differences is not known
but could be due to low basal levels of msx1
expression in suppressed Fwd clones.
controlled transactivator (tTA) (Gossen and Bujard, induction, a 2.1 kb msx1 signal was observed in C2C12-
LINX-msx1-fwd (Fwd) clones. Phosphorimage analysis1992; Hoshimaru et al., 1996). Tetracycline or its analog,
doxycycline, will bind to and inactivate tTA, preventing revealed a 25-fold induction in msx1 expression. Induc-
ible expression could be reversed when msx1 was againtranscription from the minimal CMV promoter. In the
absence of these antibiotics, tTA binds to the tetracy- suppressed by growth in medium containing 2 mg/ml
doxycycline. C2C12 myoblasts and clones containingcline response elements (TRE) and induces transcrip-
tion. C2C12 myoblasts were transduced with the LINX- the LINX-msx1-rev construct (Rev) did not express
msx1.msx1-fwd or LINX-msx1-rev retroviral vectors and
clones were isolated and propagated. Ectopic expression of msx1 has been shown to inhibit
the differentiation of mouse myoblasts into myotubesClones were tested for msx1 inducibility by growing
the myoblasts in the presence or absence of doxycy- (Song et al., 1992). We performed a similar analysis on
the C2C12-LINX-msx1 clones to assess whether thecline. Total RNA was extracted from the cell cultures
and Northern blots were prepared to assess the induc- induced msx1 protein was functional. The myoblast
clones were grown in conditions that either induced oribility of msx1 expression (Figure 1B). After five days of
msx1 Induces Mouse Myotube Dedifferentiation
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suppressed msx1 expression. Once cellular confluence this procedure in either Fwd or control myotubes. msx1
expression was then induced in one set of Fwd myo-was reached, growth medium was replaced with differ-
tubes, while a control set of myotubes remained sup-entiation medium and induction or suppression of msx1
pressed. Both sets of myotubes were stimulated withwas continued. For over a period of ten days, the clones
growth medium and followed daily for up to 7 days bywere observed for morphologic signs of differentiation
microscopic observation and photography.by phase contrast microscopy. Fwd clones that were
Dedifferentiation was assessed by morphologic ex-cultured in conditions that suppressed msx1 expression
amination using the following criteria: (1) cleavage ofreadily produced myotubes, while those expressing
the myotubes into mononucleated cells or smaller myo-msx1 failed to produce myotubes (Figure 1C). Control
tubes, and (2) proliferation of the myotube-derivedC2C12 myoblasts and Rev clones differentiated nor-
mononucleated cells. Figure 3A shows an example of amally when treated with the induction or suppression
large multinucleated myotube that cleaved to form twoconditions (Figure 1C and data not shown). Taken to-
smaller multinucleated myotubes. Cleavage of this largegether, these results indicate that the Fwd clones con-
myotube was almost complete at day 5 of msx1 induc-tain an inducible msx1 gene that produces functional
tion. Once cleaved, the two myotubes remained sepa-msx1 protein. Two Fwd clones (Fwd-2 and Fwd-3) and
rated and viable through the duration of the dedifferenti-one Rev clone (Rev-2) were chosen for further study.
ation assay (up to day 7 postinduction). Cleavage of
large myotubes into smaller myotubes was never ob-msx1 Reverses Expression of Muscle
served in control myotube cultures (Figure 3B). Of theDifferentiation Proteins in Mouse Myotubes
148 test myotubes treated with the induction conditions,One biochemical indicator of myotube dedifferentiation
13 (8.8%) underwent cleavage to form either smallerwould be the reduction in levels of myogenic differentia-
myotubes or mononucleated cells (Figures 4 and 5).tion proteins. To determine if the myogenic factors
Figure 4 shows an example of three myotubes thatMyoD, myogenin, MRF4, and p21 are reduced as a con-
dedifferentiate into proliferating mononucleated cells.sequence of msx1 expression, we performed indirect
The first signs of dedifferentiation were evident two daysimmunofluorescence assays on myotubes that had
following induction of msx1 (Figures 4A and 4D). At thisbeen induced to express msx1 in the presence of growth
time, the left myotube in Figure 4A had completelymedium. All of these myogenic factors were reduced to
cleaved to form mononucleated cells. The right myotubevarying degrees in murine myotubes (Figure 2). Within
also showed signs of cleavage. The cell had stretched1 day of msx1 induction, MRF4 was reduced to unde-
and was beginning to cleave at the upper end. Thistectable levels in 34% of induced myotubes. Likewise,
cleavage eventually produced proliferating, mononucle-myogenin was undetectable in approximately 25% of
ated cells by day 4.5 (Figures 4A and 4B). By day 2.5,all induced myotubes. The percentage of myotubes
the mononucleated cells derived from the left myotubeshowing undetectable levels of MRF4 and myogenin
were rapidly proliferating. From days 3–4.5, additionalrose through days 2 and 3 to 50% and 38%, respectively.
signs of cleavage were apparent in the right myotube,MyoD expression was not affected until the second day
where mononucleated cells appear to emerge from theof msx1 induction. On day 2, 10% of all myotubes exhib-
core of the myotube (Figure 4C). The mononucleatedited a marked reduction of MyoD levels and this percent-
cells arising from these two myotubes continued to pro-age rose to 28% by day 3. The percentage of myotubes
liferate and reached cellular confluence by day 7. Figureexhibiting undetectable levels of p21 rose from 10% on
4D shows another example of a small myotube thatday 1 post-induction to 20% by day 3. To ensure that
begins to cleave by day 2 of msx1 induction. Prolifera-
the observed reduction of myogenic protein levels of
tion of the resulting mononucleated cells was evident
test myotubes was not the result of myotube aging,
by day 5 and on day 6 numerous myotube-derived
control myotubes were matched for age. Normal expres- mononucleated cells were present. Of 148 test myo-
sion of muscle proteins was observed in 90%–100% tubes treated with the induction conditions, 8 (5.4%)
of control C2C12 myotubes (Figure 2). These results dedifferentiated to a pool of proliferating mononucle-
indicate that ectopic msx1 expression can cause a re- ated cells (Figure 5). Thus, msx1 can induce myotubes
duction in the levels of myogenic proteins in terminally to stretch and cleave, giving rise to smaller myotubes
differentiated mammalian myotubes. or mononucleated cells that proliferate.
To ensure that myotube cleavage to mononucleated
msx1 Induces Mouse Myotube Cleavage cells and subsequent proliferation resulted from msx1
and Cellular Proliferation expression and was not an artifact of hidden, reserve
To test whether ectopic msx1 expression and growth mononucleated cells, we repeated these experiments
factor stimulation could induce cleavage of terminally using control cells consisting of uninduced Fwd, Rev,
differentiated mammalian myotubes, we isolated myo- and nontransduced C2C12 myotubes. Of the 151 control
tubes, plated them at low density, and eliminated the myotubes studied, only 1 atypical myotube cleaved to
remaining mononucleated cells by lethal injection and/ form a few mononucleated cells. However, these cells
or needle ablation (Kumar et al., 2000) (see Experimental did not proliferate even after 7 days in growth medium.
Procedures for details). Fresh differentiation medium No other control myotubes showed evidence of stretch-
was added to the myotubes and they were incubated ing and cleaving and no proliferating mononucleated
overnight. The cultures were again examined for residual cells were observed (Figure 4E). The Fisher-Irwin exact
mononucleated cells and those present were eliminated test indicates that the difference in cleavage frequency
before photographing the entire gridded region. No re- between msx1-expressing and control myotubes is sig-
nificant at p 5 0.0006. Likewise, the difference in cleav-sidual mononucleated cells were observed following
Cell
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Figure 2. msx1 Reduces Myogenic Protein Levels in Mouse Myotubes
(A) Control C2C12 myotubes express myogenin, p21, MRF4, and MyoD, while Fwd-3 myotube nuclei fail to express detectable levels of these
muscle proteins following msx1 induction. Arrows point to nuclei that stain for muscle protein. Arrowheads point to nuclei that fail to stain
for muscle protein. Cytoplasmic staining is also observed in myotubes in the absence of primary antibody and therefore represents nonspecific
background staining (data not shown).
(B) The percentage of mouse myotubes that exhibit undetectable levels of the myogenic proteins MRF4, myogenin, MyoD, and p21 increases
over a three day period of msx1 induction. Black bars represent data from controls; gray bars represent data from msx1-induced myotubes.
The fractions above the bars refer to the number of myotubes exhibiting undetectable levels of protein to total number of myotubes observed.
Statistically significant p values (Fisher-Irwin exact test) are also shown above the bars.
age/proliferation frequency between msx1-expressing Cells Derived from Dedifferentiated Mouse
Myotubes Show Signs of Pluripotencyand control myotubes is significant at p 5 0.003. We
conclude that the combination of ectopic msx1 expres- To determine if the dedifferentiated, proliferating mono-
nucleated cells exhibited signs of pluripotency, we iso-sion and stimulation with growth factors can induce a
percentage of mouse myotubes to dedifferentiate into lated and expanded two different clonal populations of
cells that originated from a single Fwd-2 myotube andsmaller myotubes or proliferating, mononucleated cells.
msx1 Induces Mouse Myotube Dedifferentiation
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Figure 3. msx1 Induces Stretching and Cleavage of Mouse Myotubes
(A) Ectopic msx1 expression induces a larger myotube to stretch and cleave to produce two smaller myotubes, each containing at least three
nuclei. Cleavage is almost complete by day 5 of msx1 induction. On day 5, arrows point to nuclei in the cleaving myotube. Arrowhead points
to a thin cytoplasmic connection between the nearly cleaved myotube products.
(B) A typical example of a control Rev-2 myotube that shows no signs of cleavage under induction conditions.
cultured the clones under conditions that were favorable of alkaline phosphatase–staining foci in dedifferentiated
clones when compared to controls (approximately 3500for either chondrogenesis, adipogenesis, osteogenesis,
or myogenesis (Grigoriadis et al., 1988; Jaiswal et al., foci per 35 mm plate versus 36 foci per plate) (Figure
6). By RT-PCR, dedifferentiated clones also expressed1997; Mackay et al., 1998; Dennis et al., 1999; Pittenger
et al., 1999). Each clone was originally derived from a the osteogenic markers, osteocalcin and osteopontin.
Following 20 PCR thermocycles, the osteocalcin andsingle dedifferentiated cell using limiting dilution in 96-
well plates as described in the Experimental Procedures osteopontin amplification products in the dedifferenti-
ated clones were present at high levels, while the Rev-2section. msx1 expression was suppressed during these
redifferentiation assays. control clone exhibited no amplification of osteocalcin
and only a faint osteopontin product (data not shown).The dedifferentiated clones were tested for chondro-
genic potential by pelleting 2.5 3 105 cells in chondro- Dedifferentiated clones readily formed myotubes in
ADM or OIM as identified by morphology and reactivitygenic differentiation medium and feeding the cell pellets
every two days with fresh medium. The clonal cell popu- to an anti-myogenin antibody (Figure 6). As expected,
control C2C12 and Rev-2 myoblasts also readily differ-lations readily differentiated into cells that produced an
extracellular matrix staining faintly with alcian blue (data entiated into myotubes (Figure 6 and data not shown).
These data suggest that the combination of ectopicnot shown) and containing collagen type II (Figure 6),
suggesting that these cells had differentiated into chon- msx1 expression and growth factor treatment can in-
duce terminally differentiated mouse myotubes to dedif-drocytes. Redifferentiated cells could be further induced
to produce type X collagen (Figure 6), a marker for hyper- ferentiate to a pool of proliferating, mononucleated cells.
Clonal populations of these cells (each originally derivedtrophic chondrocytes. No C2C12 or Rev-2 cells could
be induced to produce these markers of chondrogenesis from a single dedifferentiated cell) were capable of redif-
ferentiating into cells that express markers for several(Figure 6 and data not shown).
When cultured in adipogenic differentiation medium different cell lineages.
(ADM) for 7–16 days, the dedifferentiated clones pro-
duced cells characterized by typical adipocyte morphol-
ogy and numerous vacuoles that stained bright orange msx1 Induces Transdetermination
of Mouse Myoblastsupon treatment with the lipophilic dyes, Oil Red O and
Nile Red (Figure 6). Control C2C12 and Rev-2 cells uni- We reasoned that if msx1 expression caused terminally
differentiated myotubes to dedifferentiate, ectopic ex-formly differentiated into myotubes with no evidence of
adipocyte differentiation. (Figure 6 and data not shown). pression of msx1 might promote transdetermination of
C2C12 myoblasts. msx1 expression was induced in FwdThe combination of morphologic features and lipid-
staining vacuoles suggests that some of the dedifferen- myoblasts for five days and then suppressed. When
treated with the appropriate media, these cells readilytiated cells had redifferentiated into adipocytes.
Dedifferentiated clones could also be induced to dif- differentiated into cells that express chondrogenic, adi-
pogenic, myogenic, or osteogenic markers (Figure 7).ferentiate into cells expressing three osteogenic mark-
ers by treatment with osteogenic-inducing medium No histochemical or immunohistochemical evidence of
transdetermination was observed in control C2C12 or(OIM). We observed a 100-fold increase in the number
Cell
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Figure 4. msx1 Induces Mouse Myotubes to
Cleave to Proliferating, Mononucleated Cells
(A) A series of photomicrographs taken of two
dedifferentiating myotubes over a seven day
period. Day 0, myotubes before msx1 induc-
tion. Days 1–7, myotubes and dedifferentiat-
ing myotubes following induction of msx1.
Cleavage and cellular proliferation are evi-
dent by day 2 and proliferation of the dediffer-
entiated cells continues through day 7. The
arrows and arrowheads from day 0 to day 4
indicate two dedifferentiating myotubes. The
myotube on the right (arrow) is shown at
higher magnification in (B) and (C).
(B) High power photomicrographs of the up-
per half of the dedifferentiating myotube lo-
cated on the right and denoted by the arrow
in (A). Days 0–4.5 of msx1 expression are
shown. Note that at day 2, the myotube has
stretched and begun to fragment (arrow). By
day 2.5, a small fragment has cleaved from
the myotube (arrow). During days 3.5–4, this
fragment divides (arrows). Rapid cellular pro-
liferation continues through Day 4.5.
(C) Black and white arrows point to two
groups of myotube-derived cells that are ac-
tively cleaving or dividing. Note that the cells
indicated by the black arrow originate from
the core of the myotube.
(D) Dedifferentiation of a small myotube. At
day 1, the myotube is still intact. By day 2, it
has begun to cleave. Cellular proliferation is
evident by days 5–6.
(E) An example of a C2C12 control myotube
over a period of seven days under induction
conditions. Note that the myotube changes
morphology over the seven day period but
does not cleave.
Cleavage/proliferation of control myotubes
was never observed.
Rev-2 cells. These results suggest that msx1 can induce myotubes upon growth factor removal, will rapidly prolif-
transdetermination of myoblasts. erate when placed in growth medium (Yoshida et al.,
1998). We used the same procedures to eliminate re-
serve cells from test and control myotube cultures. OnlyDiscussion
msx1-expressing myotubes produced proliferating
mononucleated cells, while no such cellular proliferationWe conclude that terminally differentiated mouse myo-
was observed in controls (p 5 0.003). If residual reservetubes can cleave to form smaller myotubes or proliferat-
cells remained following our careful elimination proce-ing mononucleated cells when challenged with msx1
dures, one would expect to see marked proliferation ofand growth factors. The dedifferentiated mononucle-
these cells in both msx1-expressing and control culturesated cells can be induced to redifferentiate into cells
following growth medium stimulation. The fact that cel-that express chondrogenic, adipogenic, myogenic, or
lular proliferation was never observed in control myo-osteogenic markers. Given that clonal populations of
tube cultures strongly suggests that reserve cells are notdedifferentiated cells were used in the redifferentiation
responsible for the apparent dedifferentiation events.assays, these results suggest that at least some of the
It is also difficult to explain our data by suggestingdedifferentiated cells are pluripotent. Comparable phe-
the presence of unobserved satellite cells. In vivo, satel-nomena were never observed in control cells. Thus,
lite cells are quiescent, mononucleated cells that residemammalian myotubes have the potential to dedifferenti-
between the basal lamina and sarcolemma of myofibersate when stimulated with appropriate factors such as
and are the precursors to the proliferating myoblastsmsx1.
that regenerate lost myofibers following muscle degen-It is difficult to explain our data by evoking the pres-
eration. One could hypothesize that the combination ofence of unobserved reserve cells. Reserve cells, which
are mononucleated cells that do not differentiate into msx1 expression and serum stimulation might cause
msx1 Induces Mouse Myotube Dedifferentiation
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Figure 5. Percentage of Mouse Myotubes Exhibiting Morphologic
Dedifferentiation Following msx1 Expression
Ectopic expression of msx1 caused 8.8% of the C2C12 myotubes
to cleave to form either smaller myotubes or mononucleated cells.
More than half of these cleaved myotubes produced dedifferenti-
ated mononucleated cells that continued to proliferate (5.4% of
all myotubes). Black bars represent data from controls; gray bars
represent data from msx1-induced myotubes. The fractions above
the bars refer to the number of dedifferentiated myotubes over the
total number of myotubes observed. Statistically significant p values
(Fisher-Irwin exact test) are shown above the bars.
satellite cells to rapidly proliferate and produce multiple
mononucleated cells. This explanation, however, is in-
consistent with the following observations. First, we saw
no evidence of attached satellite cells, which produce
readily visible bulges along the edges of myofibers in
primary culture (Cornelison and Wold, 1997). Second,
msx1 expression reduced the levels of nuclear myogenic Figure 6. Mononucleated Cells Derived from Dedifferentiated
proteins in terminally differentiated myotubes. This Mouse Myotubes Exhibit Signs of Pluripotency
early, independent evidence of cellular dedifferentiation Clones were isolated from mononucleated cells originally derived
was observed in intact myotubes before any cleavage from a dedifferentiated Fwd-2 myotube. These clonal populations
were subjected to chondrogenic, osteogenic, adipogenic, and myo-and cellular proliferation had occurred. The presence of
genic inducing signals and tested for differentiation. Dedifferentia-residual mononucleated cells or satellite cells cannot
tion clone 1 (Fwd-2-D1) differentiated into cells expressing collagenexplain the reduction in levels of myogenic proteins in
type II and collagen type X (markers for chondrogenesis), alkalinemyotubes. Third, as shown in Figure 3, we observed
phosphatase (a marker for osteogenesis), and myogenin (marker for
large multinucleated myotubes that cleaved to form myogenesis). Some cells exhibited vacuoles that stain with Oil Red
smaller multinucleated myotubes. Such cleavage events O or Nile Red (markers for adipogenesis). Controls (C2C12 or Rev-2
cells) only differentiated into myotubes, consistent with their myo-were not observed in control myotubes and cannot be
genic commitment.explained by the presence of reserve or satellite cells.
Taken together, these results provide strong evidence
against the interpretation that the observed cleavage of tumor suppressor proteins can have a similar effect
on myotubes. The nuclei of mouse myotubes lackingand cellular proliferation events resulted from the con-
tamination of our cultures with satellite or reserve cells. the retinoblastoma protein will reenter the cell cycle
when stimulated with growth factors (Schneider et al.,Rather, these results support the conclusion that murine
myotubes can dedifferentiate in response to msx1 ex- 1994; Novitch et al., 1996). Furthermore, the synthetic
purine microtubule binding molecule, myoseverin, canpression and growth factor stimulation.
Previous studies have demonstrated that mammalian cause C2C12 myotubes to cleave and the resulting
mononucleated cells will proliferate when grown inmyotubes can reenter the cell cycle and/or alter gene
expression if exposed to viral oncogenes. For example, growth medium (Rosania et al., 2000). Whether the myo-
severin- and msx1-mediated cleavage of myotubesthe adenoviral oncogene E1A causes nuclei in mouse
myotubes to reenter the cell cycle and reduces the levels share overlapping molecular pathways is not known.
However, the mononucleated cells derived from myo-of muscle-specific contractile proteins. Likewise, ec-
topic expression of the SV40 large T antigen will induce severin cleavage continue to express the myogenic dif-
ferentiation factors and therefore are not completelythe nuclei of mouse or rat myotubes to reenter the cell
cycle and a subset of these myotubes will cytokinetically dedifferentiated. Although these previous studies sug-
gest that mammalian myotubes may retain a latent abil-cleave to produce smaller myotubes or individual non-
proliferating mononucleated cells (Endo and Nadal- ity to respond to dedifferentiation signals, they do not
represent examples of complete dedifferentiation.Ginard, 1989, 1998; Iujvidin et al., 1990). The absence
Cell
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imately 9% of the myotubes begin to cleave and 5%
form a pool of proliferating, mononucleated cells. These
percentages are consistent with those observed in vivo
during newt regeneration. By transplanting fluorescently
labeled myotubes into newt regeneration blastemas, Lo
et al. (1993) estimated that approximately 10%–15% of
the myotubes dedifferentiated to form mononucleated
cells. Thus, the in vitro frequency of mammalian myo-
tube dedifferentiation in our study is similar to that ob-
served in vivo in an organism known to exhibit a remark-
able propensity for cellular plasticity.
Previous studies have implicated msx1 in the mainte-
nance of the undifferentiated state and suggest that
msx1 may be playing a role in the dedifferentiation pro-
cess in vivo. First, msx genes are expressed early in
the regenerative response soon after amputation of the
urodele limb or zebrafish fin, suggesting that these tran-
scription repressors may be important for maintaining
and possibly inducing pluripotency (Akimenko et al.,
1995; Simon et al., 1995; Poss et al., 2000). Second,
msx1 expression in the developing mouse limb demar-
cates the boundary between the undifferentiated msx1-
expressing cells and differentiating nonexpressing cells
(Hill et al., 1989; Robert et al., 1989). Third, if amputations
are performed in developing mice through the region of
msx1 expression, the lost portion will regenerate and a
normal digit will develop (Reginelli et al., 1995). Finally,
msx1 expression is correlated with digit tip regeneration
in adult mice (Reginelli et al., 1995). Previous in vitro
studies also suggest that msx1 may play a role in induc-
ing cellular dedifferentiation. Ectopic expression of ei-
ther murine or human msx1 will inhibit in vitro myogen-
esis in cultured mouse cells and downregulate MyoD
expression in myoblasts (Song et al., 1992; Woloshin et
al., 1995). This downregulation of MyoD expression
Figure 7. msx1 Induces Transdetermination of C2C12 Myoblasts
could suggest that these myoblasts had dedifferentiated
C2C12 myoblasts that have ectopically expressed msx1 can be
to an earlier progenitor cell type. Thus, previous in vivotransdetermined to cells that express markers for chondrogenesis,
data are consistent with the hypothesis that msx1 playsadipogenesis, and osteogenesis. Alcian blue staining and reaction
a role in dedifferentiation and cellular plasticity.with antibodies to collagen type II and collagen type X indicate
chondrogenic differentiation. Oil Red O staining and alkaline phos- Our data suggest that msx1 can induce myotubes to
phatase expression suggest adipogenic and osteogenic differentia- dedifferentiate to cells with properties similar to stem
tion, respectively, while myogenin expression indicates myogenesis. cells. Clonal populations of dedifferentiated cells were
Rev-2 and C2C12 controls are not transdetermined under these able to redifferentiate into cells expressing the chondro-
conditions.
genic markers, collagen II and collagen X. These cells
also stained with alcian blue, a dye that reacts with the
extracellular matrix laid down by chondrocytes. Dedif-
By contrast, our results suggest that murine myotubes ferentiated clones could also redifferentiate into cells
can dedifferentiate to form proliferating cells with prop- with typical adipocyte morphology that stained with the
erties similar to stem cells. The first stage of dedifferenti- lipophilic dyes, Oil red O and Nile red. Increased alkaline
ation involves the reduction of myogenic protein levels phosphatase activity and expression of the osteogenic
in intact myotubes. The temporal order of this reduction markers, osteocalcin and osteopontin, demonstrated
appears to be a reversal of the order of induction during that the dedifferentiated clones could also redifferenti-
myogenesis. For example, during in vitro muscle differ- ate into cells expressing osteogenic markers. Lastly,
entiation, MyoD is expressed first, followed in order by myogenic potential of these cells was demonstrated by
myogenin, p21/WAF1, and then other muscle differenti- typical myotube morphology and myogenin staining of
ation proteins (Andres and Walsh, 1996; Walsh and Perl- nuclei within the multinucleated cells. Control C2C12
man, 1997). Our data indicate that during dedifferentia- and Rev-2 cells did not exhibit any of these indicators
tion, MRF4, p21, and myogenin levels are initially of pluripotency but instead redifferentiated into cells
reduced, followed by a reduction in MyoD levels. By day exhibiting typical myotube morphology. These differ-
three of msx1 induction, 20%–50% of the myotubes ences between the dedifferentiated clones and controls
have nuclei with undetectable levels of these muscle in response to known stimulators of chondrogenesis,
differentiation proteins. adipogenesis, and osteogenesis strongly suggest that
Following the reduction of muscle protein levels, the the dedifferentiated cells had increased their cellular
potency. In addition, our transdetermination data sug-second stage of dedifferentiation occurs, where approx-
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serum (FBS, Clontech No. 8630–1), 2 mM glutamine, 100 mg/mlgest that msx1 greatly enhances cellular plasticity of
penicillin, 100 units/ml streptomycin, and DMEM (GIBCO-BRL No.C2C12 cells. In the absence of msx1, C2C12 cells and
11995-065). Cells were transfected for 10 hr. Medium was replacedother myoblast cell lines exhibit a limited degree of
and cells were grown an additional 48 hr. The retroviral-containing
cellular plasticity. The murine myoblast cell lines C2C12 conditioned medium was then harvested and live cells were re-
and G8 can be transdetermined to adipocytes when moved by centrifugation at 500 3 g.
C2C12 cells were grown to 20% cellular confluence in growthtreated with fatty acids or thiazolidinediones (Teboul
medium containing 20% tetracycline-tested FBS, 4 mM glutamine,et al., 1995; Grimaldi et al., 1997) or when forced to
and 2 mg/ml doxycycline in DMEM (GM-dox). C2C12 cells wereectopically express peroxisome proliferator-activated
infected with the LINX-msx1-fwd or LINX-msx1-rev recombinantreceptor-g (PPAR-g) or CCAAT/enhancer binding pro-
retroviruses in T25 tissue culture flasks by replacing GM with retrovi-
tein-a (C/EBP-a) (Hu et al., 1995). C2C12 cells can also ral-containing medium comprised of 1 ml retroviral conditioned me-
be transdetermined to osteoblasts when treated with dium, 2 ml GM, and 4 mg/ml Polybrene. Cells were incubated at
378C/5% CO2 for 12–18 hr, and the medium was replaced with freshbone morphogenetic protein-2 (BMP-2) (Katagiri et al.,
GM. The cells were incubated an additional 48 hr and then switched1994; Namiki et al., 1997; Nishimura et al., 1998). How-
to a 378C/10% CO2 incubator. Cells were split just before theyever, we observed no histochemical or immunohisto-
reached cellular confluence and selection in G418 (750 mg/ml) waschemical evidence of chondrogenesis, adipogenesis, or
initiated. Selection continued for 6 days and then the cells were
osteogenesis when control C2C12 cells were treated split into 100 mm tissue culture plates at a density of 50 cells/plate.
with the specific differentiation media used in this study. Selection was continued for an additional 8 days. Individual cell
colonies were isolated using cloning cylinders and these clonesOnly dedifferentiated cells derived from msx1-express-
were expanded in GM-G418. Clones were tested for inducible msx1ing myotubes and myoblasts that previously expressed
expression by Northern analysis of total RNA and inhibition of myo-msx1 showed enhanced cellular plasticity under these
cyte differentiation in reduced growth factor medium.conditions. Thus, our data suggest that msx1 can induce
the dedifferentiation of myotubes to cells that are like
Immunofluorescent Studiesstem cells and can enhance plasticity of C2C12 cells.
Myotubes were produced by inducing C2C12 cells, Fwd clones,
The molecular mechanisms of msx1-induced cellular and the Rev clone to differentiate in the presence of differentiation
dedifferentiation are unknown. However, msx1 has been medium containing 2% horse serum, 4 mM glutamine, and 2 mg/ml
doxycycline in DMEM (DM-dox). Myotubes were then gently trypsin-shown to be a transcriptional repressor that downregu-
ized and replated at low density in DM-dox. The medium was re-lates MyoD (Song et al., 1992; Catron et al., 1995; Wolo-
placed with growth medium lacking doxycycline (GM) to induceshin et al., 1995; Lee et al., 1998). Here, we show that
msx1 expression in the presence of growth factors. Myotubes wereectopic msx1 expression reduces the levels of MRF4,
tested for MyoD (1/10; NCL-MyoD1, Vector Laboratories, Inc.), myo-
myogenin, and p21, as well as MyoD. It is possible, genin (1/100; F5D, Pharmingen), MRF4 (1/50; Myf-6, 242, Santa Cruz
therefore, that msx1 represses myogenic factors, either Biotechnology), and p21 (1/100; WAF1, Oncogene Research Prod-
ucts) expression by immunofluorescence on day 0 (before induction)directly or indirectly, and that these molecular events
through day 3 (postinduction). Secondary antibodies were used atultimately lead to cellular dedifferentiation.
1/200 dilution and included a biotinylated goat anti-mouse IgG anti-Our findings may have implications for the treatment
body (B-2763, Molecular Probes) and an Alexa 488-conjugated goatof degenerative diseases and for the induction of epi-
anti-rabbit IgG antibody (A-11034, Molecular Probes).
morphic regeneration in mammals. Cellular dedifferenti- Myotubes were fixed in Zamboni’s fixative for 10 min, washed
ation has been demonstrated during urodele epimorphic once with DPBS, and permeabilized with 0.2% Triton-X-100 in DPBS
for 20 min. The myotubes were blocked with 5% skim milk in DPBSregeneration and is thought to be an integral step in the
for 1 hr and then exposed to two primary antibodies (one was aregenerative process. The role msx1 appears to play
mouse monoclonal, the other a rabbit polyclonal) overnight at 48C.in inducing murine myotube dedifferentiation, coupled
The cells were washed three times with DPBS and then treatedwith the previous observation correlating murine digit
with two secondary antibodies (a goat anti-rabbit IgG conjugated
tip regeneration with msx1 expression (Reginelli et al., to Alexa 488, Molecular Probes, and a goat anti-mouse IgG conju-
1995), suggests that greater regenerative capacity in gated to biotin) for 45 min at 378C. Myotubes were washed three
times with DPBS and then exposed to 1 mg/ml streptavidin-Alexamammals may be feasible. Future transgenic and gene
594 (S-11227, Molecular Probes) for 45 min at 378C. The cells weretherapy experiments will determine if msx1 can induce
washed three times with DPBS and observed with a Zeiss Axiovertcellular dedifferentiation in vivo and modulate mamma-
100 inverted microscope using FITC and Texas Red filters.lian regenerative capacity.
Morphologic Dedifferentiation Assays
Experimental Procedures The bottoms of 35 mm tissue culture plates were scored into 6 3
4 mm grids using a razor blade and ruler. The plates were then
Construction of Retroviral Vector coated with 0.75% gelatin. Myotubes were prepared as described
A 1.2 kb DNA fragment containing the entire coding region of the above, gently trypsinized with 0.25% trypsin/1 mM EDTA and re-
mouse msx1 gene was excised from the plasmid phox7XS (a gift plated in DM-dox at a density of 2–4 myotubes/mm2 on gridded 35
from Robert E. Hill) using SacI and XbaI, blunt-ended with dNTPs mm gelatinized plates. The following day, residual mononucleated
and Klenow fragment, and ligated into the LINX retroviral vector (a cells were destroyed by lethal injection of water (cells burst) and/
gift from Fred Gage) at the blunted ClaI site. Clones containing the or needle ablation using an Eppendorf microinjection system (Kumar
msx1 gene in both the forward (LINX-msx1-fwd) and reverse (LINX- et al., 2000). The medium was then replaced with fresh DM and the
msx1-rev) orientations were identified and used for the transduction cells were incubated overnight. The next day, plates were examined
studies. for residual mononucleated cells and these were ablated when
found. One or more 6 3 4 mm grids were chosen for examination
over a 7 day period and these were photographed at 253 using theTransduction of C2C12 Cells and Selection of Clones
Harboring Inducible msx1 103 objective. This produced a series of 16 adjacent photographs
for each 6 3 4 mm grid. Thus, the entire 6 3 4 mm grid was recordedPhoenix-Ampho cells (American Type Culture Collection, ATCC No.
SD3443) were grown to 70%–80% cellular confluence in growth by photography. The myotubes were then induced to express msx1
in the presence of growth factors by replacing the culture mediummedium (GM-`) containing 10% tetracycline-tested fetal bovine
Cell
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with GM (minus doxycycline). The cells were observed and photo- events that precede cell fusion upon myogenesis. J. Cell Biol. 132,
657–666.graphed as described above every 12–24 hr for up to seven days.
Myotubes that appeared to be responding to the treatment were Becker, R.O., Chapin, S., and Sherry, R. (1974). Regeneration of the
also photographed at 503 or 803 using the 203 or 323 objectives, ventricular myocardium in amphibians. Nature 248, 145–147.
respectively.
Bodemer, C.W., and Everett, N.B. (1959). Localization of newly syn-
thesized proteins in regenerating newt limbs as determined by radio-
Transdetermination and Pluripotency Assays autographic localization of injected methionine-S35. Dev. Biol. 1,
for Dedifferentiated Cells 327–342.
msx1 expression was induced in Fwd clones for five days in the Brockes, J.P. (1997). Amphibian limb regeneration: rebuilding a
absence of doxycycline and then suppressed an additional five days complex structure. Science 276, 81–87.
in the presence of 2 mg/ml doxycycline. Control Rev-2 and C2C12
Catron, K.M., Zhang, H., Marshall, S.C., Inostroza, J.A., Wilson, J.M.,cells were treated similarly. In addition, two clonal populations of
and Abate, C. (1995). Transcriptional repression by Msx-1 does notcells (each originally derived from a single cell) were isolated from
require homeodomain DNA-binding sites. Mol. Cell. Biol. 15,a dedifferentiated Fwd-2 myotube by plating at limiting dilution in
861–871.96-well plates. The above cells were used in the following assays
Chalkley, D.T. (1954). A quantitative histological analysis of forelimbfor transdetermination and pluripotency.
regeneration in Tritutus viridescens. J. Morphol. 94, 21–70.Chondrogenic potential was assessed in the presence of 2 mg/
ml doxycycline according to published protocols (Mackay et al., Cornelison, D.D.W., and Wold, B.J. (1997). Single-cell analysis of
1998; Dennis et al., 1999). The cell pellets were treated with O.C.T. regulatory gene expression in quiescent and activated mouse skele-
compound (Tissue-Tek), rapidly frozen, and stored at 2808C. Alter- tal muscle satellite cells. Dev. Biol. 191, 270–283.
natively, the cell pellets were fixed overnight at 48C in 4% paraform- Davis, B.M., Ayers, J.L., Koran, L., Carlson, J., Anderson, M.C., and
aldehyde, processed through a series of ethanol/Hemo-De washes, Simpson, S.B., Jr. (1990). Time course of salamander spinal cord
and embedded in paraffin. Paraffin-embedded cell pellets were sec- regeneration and recovery of swimming: HRP retrograde pathway
tioned and stained with alcian blue (either in 3% acetic acid [pH tracing and kinematic analysis. Exp. Neurol. 108, 198–213.
2.5] or in 10% sulfuric acid [pH 0.2]). Frozen sections were stained
Dennis, J.E., Merriam, A., Awadallah, A., Yoo, J.U., Johnstone, B.,for collagen type II using the Vectastain Elite ABC kit according to
and Caplan, A.I. (1999). A quadripotential mesenchymal progenitorthe manufacturer’s instructions (Vector Laboratories), except that
cell isolated from the marrow of an adult mouse. J Bone Miner. Res.samples were treated with 3% H2O2 in methanol for 30 min following 14, 700–709.hydration and then with 50 mU/ml chondroitinase ABC for 30 min.
Endo, T., and Nadal-Ginard, B. (1989). SV40 large T antigen inducesAnti-collagen type II and type X (1/50; NeoMarkers, Lab Vision Corp.)
reentry of terminally differentiated myotubes into the cell cycle. Inwere used as primary antibodies, while the secondary antibody was
Cellular and Molecular Biology of Muscle Development, F. Stock-biotinylated (1/200). Samples were counterstained with hematoxylin.
dale, and L. Kedes, eds. (New York, Alan R. Liss, Inc.), pp. 95–104.To assess adipogenic potential, cells were cultured for up to 20
days in GM containing 2 mg/ml doxycycline, 50 mg/ml ascorbic Endo, T., and Nadal-Ginard, B. (1998). Reversal of myogenic terminal
acid 2-phosphate, 10 mM b-glycerophosphate, and 1026 or 1027 M differentiation by SV40 large T antigen results in mitosis and apo-
dexamethasone (Grigoriadis et al., 1988). Medium was changed ptosis. J. Cell Sci. 111, 1081–1093.
every two days and cultures were monitored for morphologic signs Gossen, M., and Bujard, H. (1992). Tight control of gene expression
of adipogenic differentiation. At 14–19 days following induction of in mammalian cells by tetracycline-responsive promoters. Proc.
differentiation, the cells were fixed with 10% neutral buffered forma- Natl. Acad. Sci. USA 89, 5547–5551.
lin for 5 min, rinsed three times with ddH2O, stained with either 0.3% Grigoriadis, A.E., Heersche, J.N., and Aubin, J.E. (1988). Differentia-
w/v Oil Red O for 7 min or 100 ng/ml Nile Red for 5 min, and
tion of muscle, fat, cartilage, and bone from progenitor cells present
rinsed three times with ddH2O. Cells stained with Oil Red O were in a bone-derived clonal cell population: effect of dexamethasone.
counterstained with hematoxylin. Cells stained with Nile Red were
J. Cell Biol. 106, 2139–2151.
observed with fluorescent microscopy using a rhodamine or FITC
Grimaldi, P.A., Teboul, L., Inadera, H., Gaillard, D., and Amri, E.Z.filter.
(1997). Trans-differentiation of myoblasts to adipocytes: triggeringOsteogenic potential was assessed in the presence of 2 mg/ml
effects of fatty acids and thiazolidinediones. Prostaglandins Leukot.doxycycline using the method described by Jaiswal et al. (1997).
Essent. Fatty Acids 57, 71–75.Cells were stained for alkaline phosphatase according to manufac-
Hay, E.D., and Fischman, D.A. (1961). Origin of the blastema inturer’s instructions using Sigma Kit 85. Myogenic potential was as-
regenerating limbs of the newt Triturus viridescens. An autoradio-sessed by morphologic observation and immunofluorescence using
graphic study using tritiated thymidine to follow cell proliferationan antibody that recognizes myogenin (see section entitled Immuno-
and migration. Dev. Biol. 3, 26–59.fluorescent Studies). Myotubes were observed in cultures treated
to assess adipogenic or osteogenic potential. Hill, R.E., Jones, P.F., Rees, A.R., Sime, C.M., Justice, M.J., Cope-
land, N.G., Jenkins, N.A., Graham, E., and Davidson, D.R. (1989).
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